vs

Side-by-side financial comparison of MSCI Inc. (MSCI) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

MSCI Inc. is the larger business by last-quarter revenue ($822.5M vs $665.5M, roughly 1.2× Natera, Inc.). MSCI Inc. runs the higher net margin — 34.6% vs 7.1%, a 27.5% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 10.6%). MSCI Inc. produced more free cash flow last quarter ($488.7M vs $37.8M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 10.0%).

MSCI Inc. is an American finance company headquartered in New York City. MSCI is a global provider of equity, fixed income, real estate indices, multi-asset portfolio analysis tools, ESG and climate finance products. It operates the MSCI World, MSCI Emerging Markets, and MSCI All Country World (ACWI) indices, among others.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

MSCI vs NTRA — Head-to-Head

Bigger by revenue
MSCI
MSCI
1.2× larger
MSCI
$822.5M
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+29.2% gap
NTRA
39.8%
10.6%
MSCI
Higher net margin
MSCI
MSCI
27.5% more per $
MSCI
34.6%
7.1%
NTRA
More free cash flow
MSCI
MSCI
$450.9M more FCF
MSCI
$488.7M
$37.8M
NTRA
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
10.0%
MSCI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MSCI
MSCI
NTRA
NTRA
Revenue
$822.5M
$665.5M
Net Profit
$284.7M
$47.3M
Gross Margin
Operating Margin
56.4%
-3.4%
Net Margin
34.6%
7.1%
Revenue YoY
10.6%
39.8%
Net Profit YoY
-6.8%
187.9%
EPS (diluted)
$3.81
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSCI
MSCI
NTRA
NTRA
Q4 25
$822.5M
$665.5M
Q3 25
$793.4M
$592.2M
Q2 25
$772.7M
$546.6M
Q1 25
$745.8M
$501.8M
Q4 24
$743.5M
$476.1M
Q3 24
$724.7M
$439.8M
Q2 24
$707.9M
$413.4M
Q1 24
$680.0M
$367.7M
Net Profit
MSCI
MSCI
NTRA
NTRA
Q4 25
$284.7M
$47.3M
Q3 25
$325.4M
$-87.5M
Q2 25
$303.6M
$-100.9M
Q1 25
$288.6M
$-66.9M
Q4 24
$305.5M
$-53.8M
Q3 24
$280.9M
$-31.6M
Q2 24
$266.8M
$-37.5M
Q1 24
$256.0M
$-67.6M
Operating Margin
MSCI
MSCI
NTRA
NTRA
Q4 25
56.4%
-3.4%
Q3 25
56.4%
-16.5%
Q2 25
55.0%
-20.2%
Q1 25
50.6%
-15.8%
Q4 24
54.5%
-13.6%
Q3 24
55.4%
-8.9%
Q2 24
54.0%
-10.6%
Q1 24
49.9%
-20.2%
Net Margin
MSCI
MSCI
NTRA
NTRA
Q4 25
34.6%
7.1%
Q3 25
41.0%
-14.8%
Q2 25
39.3%
-18.5%
Q1 25
38.7%
-13.3%
Q4 24
41.1%
-11.3%
Q3 24
38.8%
-7.2%
Q2 24
37.7%
-9.1%
Q1 24
37.6%
-18.4%
EPS (diluted)
MSCI
MSCI
NTRA
NTRA
Q4 25
$3.81
$0.36
Q3 25
$4.25
$-0.64
Q2 25
$3.92
$-0.74
Q1 25
$3.71
$-0.50
Q4 24
$3.89
$-0.41
Q3 24
$3.57
$-0.26
Q2 24
$3.37
$-0.30
Q1 24
$3.22
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSCI
MSCI
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$515.3M
Total DebtLower is stronger
$6.2B
Stockholders' EquityBook value
$-2.7B
$1.7B
Total Assets
$5.7B
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSCI
MSCI
NTRA
NTRA
Q4 25
$515.3M
Q3 25
$400.1M
$1.0M
Q2 25
$347.3M
$16.0M
Q1 25
$360.7M
$17.8M
Q4 24
$409.4M
$22.7M
Q3 24
$501.0M
$29.5M
Q2 24
$451.4M
$90.3M
Q1 24
$519.3M
$69.1M
Total Debt
MSCI
MSCI
NTRA
NTRA
Q4 25
$6.2B
Q3 25
$5.5B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.5B
Q2 24
$4.5B
Q1 24
$4.5B
Stockholders' Equity
MSCI
MSCI
NTRA
NTRA
Q4 25
$-2.7B
$1.7B
Q3 25
$-1.9B
$1.3B
Q2 25
$-886.2M
$1.2B
Q1 25
$-958.6M
$1.2B
Q4 24
$-940.0M
$1.2B
Q3 24
$-751.0M
$878.5M
Q2 24
$-734.5M
$836.5M
Q1 24
$-650.5M
$794.1M
Total Assets
MSCI
MSCI
NTRA
NTRA
Q4 25
$5.7B
$2.4B
Q3 25
$5.4B
$1.8B
Q2 25
$5.4B
$1.8B
Q1 25
$5.3B
$1.7B
Q4 24
$5.4B
$1.7B
Q3 24
$5.4B
$1.6B
Q2 24
$5.5B
$1.5B
Q1 24
$5.5B
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSCI
MSCI
NTRA
NTRA
Operating Cash FlowLast quarter
$501.1M
$73.9M
Free Cash FlowOCF − Capex
$488.7M
$37.8M
FCF MarginFCF / Revenue
59.4%
5.7%
Capex IntensityCapex / Revenue
1.5%
5.4%
Cash ConversionOCF / Net Profit
1.76×
1.56×
TTM Free Cash FlowTrailing 4 quarters
$1.5B
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSCI
MSCI
NTRA
NTRA
Q4 25
$501.1M
$73.9M
Q3 25
$449.4M
$59.4M
Q2 25
$336.1M
$37.6M
Q1 25
$301.7M
$44.5M
Q4 24
$430.6M
$52.9M
Q3 24
$421.6M
$51.8M
Q2 24
$349.2M
$4.0M
Q1 24
$300.1M
$27.0M
Free Cash Flow
MSCI
MSCI
NTRA
NTRA
Q4 25
$488.7M
$37.8M
Q3 25
$445.5M
$37.0M
Q2 25
$324.7M
$11.7M
Q1 25
$290.2M
$22.6M
Q4 24
$416.4M
$34.8M
Q3 24
$415.0M
$35.5M
Q2 24
$340.6M
$-7.7M
Q1 24
$295.9M
$6.7M
FCF Margin
MSCI
MSCI
NTRA
NTRA
Q4 25
59.4%
5.7%
Q3 25
56.2%
6.2%
Q2 25
42.0%
2.1%
Q1 25
38.9%
4.5%
Q4 24
56.0%
7.3%
Q3 24
57.3%
8.1%
Q2 24
48.1%
-1.9%
Q1 24
43.5%
1.8%
Capex Intensity
MSCI
MSCI
NTRA
NTRA
Q4 25
1.5%
5.4%
Q3 25
0.5%
3.8%
Q2 25
1.5%
4.7%
Q1 25
1.5%
4.3%
Q4 24
1.9%
3.8%
Q3 24
0.9%
3.7%
Q2 24
1.2%
2.8%
Q1 24
0.6%
5.5%
Cash Conversion
MSCI
MSCI
NTRA
NTRA
Q4 25
1.76×
1.56×
Q3 25
1.38×
Q2 25
1.11×
Q1 25
1.05×
Q4 24
1.41×
Q3 24
1.50×
Q2 24
1.31×
Q1 24
1.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSCI
MSCI

Recurring Subscriptions$246.4M30%
Asset Based Fees$211.7M26%
Analytics Segment$182.3M22%
Sustainability And Climate Segment$90.3M11%
Other$70.9M9%
Non Recurring$21.1M3%

NTRA
NTRA

Segment breakdown not available.

Related Comparisons